SOPHiA GENETICS to Host Investor Day on September 20, 2022, in New York City

Rhea-AI Summary

SOPHiA GENETICS (Nasdaq: SOPH) has announced its inaugural Investor Day scheduled for September 20, 2022, at PUBLIC Hotel in New York City. The event will commence at 1:30 p.m. EDT and conclude by approximately 5:30 p.m. EDT. Presentations will be made by CEO Dr. Jurgi Camblong and the executive leadership team, followed by a Q&A session and reception. Due to limited capacity, registration is required. The event will also be available via live webcast, with replays accessible the next day.

BOSTON and LAUSANNE, Switzerland, Aug. 04, 2022 (GLOBE NEWSWIRE) -- SOPHiA GENETICS SA (Nasdaq: SOPH), a cloud-native software company in the healthcare space, announced today it will host its first-ever Investor Day on Tuesday, September 20, 2022, at PUBLIC Hotel in New York City. The event will begin at 1:30 p.m. EDT and is expected to conclude at approximately 5:30 p.m. EDT.

The event will feature presentations from the CEO and Co-Founder, Dr. Jurgi Camblong as well as from other members of the executive leadership team, followed by a Q&A session and reception.

Due to limited capacity, advanced registration is required for in-person attendance and is available by invitation. For more information, interested parties may contact Investor Relations at ir@sophiagenetics.com.

Additionally, the event will be webcast live and all interested parties are invited to access the webcast from the Investor Relations section of the company’s website. A replay of the webcast and slides shown during the presentations will also be available on the company’s website the following day.

A Media Snippet accompanying this announcement is available by clicking on the image or link below:

About SOPHiA GENETICS
SOPHiA GENETICS (Nasdaq: SOPH) is a software company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It is the creator of the SOPHiA DDM™ Platform, a cloud-native platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The SOPHiA DDM™ Platform and related solutions, products and services are currently used by a broad network of hospital, laboratory, and biopharma institutions globally. For more information, visit SOPHiAGENETICS.COM, or connect on Twitter, LinkedIn and Instagram. Where others see data, we see answers

Investor Contact:
Jennifer Pottage
Head of Investor Relations
ir@sophiagenetics.com

Media Contact:
Kelly Katapodis
Senior Manager, Media & Communications
kkatapodis@sophiagenetics.com

FAQ

What is the date of SOPHiA GENETICS' Investor Day event in 2022?

SOPHiA GENETICS' Investor Day is scheduled for September 20, 2022.

Where will SOPHiA GENETICS hold its Investor Day?

The Investor Day will be held at PUBLIC Hotel in New York City.

What time does SOPHiA GENETICS' Investor Day start?

The event begins at 1:30 p.m. EDT.

Will SOPHiA GENETICS' Investor Day include a Q&A session?

Yes, the event will feature a Q&A session following the presentations.

How can I attend SOPHiA GENETICS' Investor Day in person?

In-person attendance requires advanced registration by invitation.

Is there a webcast available for SOPHiA GENETICS' Investor Day?

Yes, the event will be webcast live and accessible from the company's website.

When will the replay of the SOPHiA GENETICS Investor Day be available?

A replay and slides will be available on the company's website the day after the event.